National Bank Of Canada Zai Lab LTD Transaction History

National Bank Of Canada

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 12, 2023	BUY	$30.21 - $48.1 $2.12 Million - $3.37 Million	70,160 Added 182.71%	108,560 $3.61 Million
Q4 2022 Jan 24, 2023	BUY	$22.28 - $38.71 $855,552 - $1.49 Million	38,400 New	38,400 $0
Q1 2022 May 05, 2022	SELL	$27.77 - $64.4 $1.6 Million - $3.71 Million	-57,600 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$54.9 - $105.21 $3.16 Million - $6.06 Million	57,600 New	57,600 $3.62 Million

123

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.55B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

Stay updated on National Bank Of Canada with notifications on news.